We are live on ! Find out more
INSP icon

Inspire Medical Systems

103 hedge funds and large institutions have $628M invested in Inspire Medical Systems in 2018 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 45 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

200% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 15

123% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 13

61% more capital invested

Capital invested by funds: $390M → $628M (+$239M)

21.62% more ownership

Funds ownership: 43.37%64.98% (+22%)

18% more funds holding

Funds holding: 87103 (+16)

Holders
103
Holders Change
+16
Holders Change %
+18.39%
% of All Funds
2.3%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
29
Increased
45
Reduced
15
Closed
13
Calls
$3.88M
Puts
Net Calls
+$3.88M
Net Calls Change
+$3.87M

INSP Hedge Fund Activity: Q4 2018 in Review

103 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q4 2018, worth a combined $628M — up 61% from $390M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new INSP positions and 13 closed out — a net gain of 16 holders — while 45 added to existing stakes and 15 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $26.1M. The largest seller was OrbiMed, cutting an estimated $26.1M.

  • 103 institutional investors held Inspire Medical Systems (INSP) as of Q4 2018, up from 87 in Q3 2018.
  • Funds reported $628M of Inspire Medical Systems stock for Q4 2018, up 61% quarter-over-quarter.
  • 29 funds opened new Inspire Medical Systems positions in Q4 2018 and 13 closed out, a net change of +16 holders.
  • The largest Inspire Medical Systems buyer in Q4 2018 was T. Rowe Price Associates, an estimated $26.1M added.
  • The largest Inspire Medical Systems seller in Q4 2018 was OrbiMed, an estimated $26.1M sold.

Based on aggregated 13F filings for Q4 2018.